Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 192 publications
Cellular stemness identifies high-risk ductal carcinoma in situ and offers a therapeutic interception opportunity.
Journal: bioRxiv : the preprint server for biology
Published: May 25, 2026
Design and preliminary report of a randomized phase IIb clinical trial of multitargeted recombinant adenovirus 5 vaccines against CEA, MUC1, and brachyury (Tri-Ad5) and the IL-15 receptor superagonist nogapendekin alfa inbakicept in Lynch syndrome (TRIAD5-Plus): the first cross-network trial of the Cancer Prevention Clinical Trials Network (CP-CTNet).
Journal: Frontiers in immunology
Published: February 11, 2026
Medium-Chain Fatty Acid exposure in non-transformed mammary glands leads to pro-tumorigenic alterations associated with aging.
Journal: bioRxiv : the preprint server for biology
Published: November 19, 2025
Contraceptive Choices for Premenopausal Women and Breast Cancer Risk.
Journal: JAMA oncology
Published: October 02, 2025
Peripheral Serum From Breast Implant-Exposed Patients Decreases Breast Cancer Cell Viability: Evidence for Immunosurveillance.
Journal: Aesthetic surgery journal
Published: September 15, 2025
Multiomic Analysis Links Neighborhood Disadvantage to Inflammatory Proteins and Tumorigenic Markers in ER+ Breast Cancer Plasma and Tumor Samples.
Journal: Journal of proteome research
Published: September 02, 2025
Quality of Life Among Patients With Ductal Carcinoma In Situ.
Journal: JAMA network open
Published: July 03, 2025
Simvastatin Treatment in Patients with Liver Cirrhosis: A Phase II Randomized Placebo-Controlled Trial Shows Reduction in IL6 Levels.
Journal: Cancer prevention research (Philadelphia, Pa.)
Published: July 02, 2025
Erratum for: MRI-based Radiomic Features for Risk Stratification of Ductal Carcinoma in Situ in a Multicenter Setting (ECOG-ACRIN E4112 Trial).
Journal: Radiology
Published: April 29, 2025
SREBP1-Dependent Metabolism as a Potential Target for Breast Cancer Risk Reduction.
Journal: Cancers
Published: April 03, 2025
MRI-based Radiomic Features for Risk Stratification of Ductal Carcinoma in Situ in a Multicenter Setting (ECOG-ACRIN E4112 Trial).
Journal: Radiology
Published: April 01, 2025
Last Updated: 09/26/2026